In vitro antiviral activity of thymoquinone and its synergistic effect with acyclovir against herpes simplex virus type 1 (HSV-1)
Journal of Herbmed Pharmacology · 01.07.2026 · 15 (3) · 365-371
DOI: 10.34172/jhp.53593 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Herbmed Pharmacology, online erschienen am 01.07.2026. Verfasst von Maryam Shirian und 5 weiteren Autor:innen. Die Arbeit nennt 32 Literaturangaben.
Abstract (Originalsprache)
Introduction
Drug resistance has heightened the demand for natural antiviral agents. Thymoquinone (TQ), a major bioactive component of black seed oil, has demonstrated antiviral activity in numerous studies. However, its potential efficacy against herpes simplex virus type 1 (HSV-1) has not been extensively explored. This research aimed to assess the in vitro antiviral effect of TQ and its synergistic relationship with acyclovir against HSV-1.
Methods
In this experimental study, the cytotoxic effects of TQ and acyclovir on Vero cells were evaluated using the MTT test. The antiviral activity of TQ and acyclovir with sub-cytotoxic doses and combinations with TQ (CC10) on HSV-1 virus replication was investigated using both MTT and 50% tissue culture infectious dose (TCID50) assays. Compusyn software was used to analyze the combination index (CI) of TQ and acyclovir.
Results
The 50% cytotoxic concentration (CC50) values of acyclovir and TQ were calculated to be 537.7 and 57.5 μM, respectively. The 50% inhibitory concentration (IC50) values of acyclovir, TQ, and acyclovir together with 10 μM TQ (CC10) were obtained to be 0.25, 13.38, and 0.04 μM, respectively. Based on the TCID50 findings, both drugs, whether used separately or in combination, significantly diminished viral titers. Synergistic effects were identified at most concentrations, with the strongest synergy observed at 0.3 μM TQ in combination with 0.03 μM acyclovir.
Conclusion
TQ possesses potent antiviral activity against HSV-1 virus and has synergistic effects with acyclovir to inhibit virus replication. Further studies need to be carried out to assess its utility and safety profile.
Zitieren
APA
Shirian, M., Jabree, Z. J. A. A., Khosravian, P., Hafizi, M., Javadi-Farsani, F., & Moradi, M. (2026). In vitro antiviral activity of thymoquinone and its synergistic effect with acyclovir against herpes simplex virus type 1 (HSV-1). Journal of Herbmed Pharmacology, 15(3), 365-371. https://doi.org/10.34172/jhp.53593
Vancouver
Shirian M, Jabree ZJAA, Khosravian P, Hafizi M, Javadi-Farsani F, Moradi M. In vitro antiviral activity of thymoquinone and its synergistic effect with acyclovir against herpes simplex virus type 1 (HSV-1). Journal of Herbmed Pharmacology. 2026;15(3):365-371. doi:10.34172/jhp.53593
BibTeX
@article{Shirian2026,
author = {Shirian, Maryam and Jabree, Zainab Jalil Awad Al and Khosravian, Pegah and Hafizi, Masoud and Javadi-Farsani, Fatemeh and Moradi, Mohammad-Taghi},
title = {In vitro antiviral activity of thymoquinone and its synergistic effect with acyclovir against herpes simplex virus type 1 (HSV-1)},
journal = {Journal of Herbmed Pharmacology},
year = {2026},
volume = {15},
number = {3},
pages = {365--371},
doi = {10.34172/jhp.53593}
}
EUVIMED